Maciej Mikulski

SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

Tomasz Rzymski, Michał Mikuła, Eliza Żyłkiewicz et al. · Oncotarget · 2017 · 98 citations · Full text

Immunology, Lineage Commitment, Cancer Biology +17

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

Zhan Yao, Jun Guo, William Yang et al. · Journal of Clinical Investigation · 2017 · 76 citations · Full text

Transcriptional Regulation, Signal Transduction, Cell Regulation +15

Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment

Olga Mucha, Paulina Podkalicka, Maciej Mikulski et al. · Archives of Biochemistry and Biophysics · 2019 · 35 citations · Full text

Heme Oxygenase Activity, Oncology, Biochemistry +10

Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties

Nicolas Boutard, Arkadiusz Białas, Aleksandra Sabiniarz et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 23 citations · Full text

Medicinal Chemistry, Pfkfb3 Inhibitors, Improved Physicochemical Properties +9

Discovery and Structure–Activity Relationships of <i>N</i>‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors

Nicolas Boutard, Arkadiusz Białas, Aleksandra Sabiniarz et al. · ChemMedChem · 2018 · 20 citations · Full text